Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
100.30%
Operating Margin
0.80%
Net Margin
0.59%
Efficiency Metrics
Revenue per Expense Ratio
1.01
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
1.25%
Income Tax Rate
18.49%
EPS
0.9900000000
Balance Sheet Analysis
Current Ratio
0.42
Cash Ratio
0.54
Working Capital
$-3.54B
Debt to Equity
0.32
Debt to Assets
6.17%
Equity Ratio
19.42%
Cash Flow Analysis
Operating Cash Flow Ratio
6.03%
Free Cash Flow Ratio
5.84%
CapEx to Revenue
0.20%
Dividends Paid
$117.20M
Stock Buybacks
No buybacks
Total Shareholder Returns
$117.20M
Cash Position Change
3.64%
Key Takeaways (2023 FY)
Increased dividend payments by 7.32%
Detailed Growth Metrics
Core Performance
Revenue
9.60%
Net Income
-69.57%
EPS
-69.63%
Operating Income
-72.93%
Operational Efficiency
R&D Expenses
0.00%
SG&A Expenses
0.00%
Operating Cash Flow
-49.92%
Free Cash Flow
-50.35%
Balance Sheet Health
Assets
4.40%
Debt
0.10%
Book Value per Share
5.72%
Inventory
-100.00%
Shareholder Returns
Dividends per Share
7.32%
Shares Outstanding
0.28%
Long Term Trends
3Y Revenue/Share
31.11%
5Y Revenue/Share
58.01%
3Y Dividend/Share
24.39%
5Y Dividend/Share
47.26%